Together with the lack of correlation between serum TARC levels and the severity of SSc-ILD, this result suggests that serum TARC levels in SSc patients might not necessarily reflect Th2 immune responses nor their contribution to SSc-ILD. The gene discussed is CCL17; the disease is interstitial lung disease.